Enhanced humoral and HLA-A2-restricted dengue virus-specific T-cell responses in humanized BLT NSG mice

Immunology

Volumn 136, Issue 3, 2012, Pages 334-343

  Jaiswal, Smita ^a   Pazoles, Pamela ^a   Woda, Marcia ^a   Shultz, Leonard D ^c   Greiner, Dale L ^b   Brehm, Michael A ^b   Mathew, Anuja ^a  

^a Division of Infectious Diseases and Immunology   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c JACKSON LABORATORY   (United States)

Author keywords

Dengue; Human; T cells; Transgenic mice; Viral

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; DENGUE VACCINE; GAMMA INTERFERON; HLA A2 ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M ANTIBODY; NEUTRALIZING ANTIBODY; VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; B LYMPHOCYTE; BLT NSG MOUSE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DENGUE; DENGUE VIRUS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; LIVER; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE; THYMUS; TRANSGENIC MOUSE; UMBILICAL CORD BLOOD; VIRUS LOAD;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; B-LYMPHOCYTES; BASE SEQUENCE; DENGUE; DENGUE VACCINES; DENGUE VIRUS; FETAL TISSUE TRANSPLANTATION; HLA-A2 ANTIGEN; HUMANS; IMMUNITY, HUMORAL; INTERFERON-GAMMA; LIVER TRANSPLANTATION; MICE; MICE, INBRED NOD; MICE, SCID; RNA, VIRAL; T-LYMPHOCYTES; THYMUS GLAND; VIRAL LOAD;

EID: 84861740934     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2012.03585.x     Document Type: Article

References (37)

1. Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 1998; 11:480-96.
2. Gubler DJ, Clark GG. Dengue/dengue hemorrhagic fever: the emergence of a global health problem. Emerg Infect Dis 1995; 1:55.
3. Endy TP, Nisalak A, Chunsuttitwat S, Vaughn DW, Green S, Ennis FA, Rothman AL, Libraty DH. Relationship of pre-existing dengue virus (DV) neutralizing antibody levels to viremia and disease severity in a prospective cohort study of DV infection in Thailand. J Infect Dis 2004; 189:990-1000.
4. Laoprasopwattana K, Libraty DH, Endy TP et al. Antibody dependent cellular cytotoxicity in pre-secondary dengue virus serotype 3 (DV3) but not in DV2 infection plasma samples inversely correlated with viremia levels. J Infect Dis 2007; 195:1108-16.
5. Libraty DH, Acosta LP, Tallo V et al. A prospective nested case-control study of dengue in infants: rethinking and refining the antibody-dependent enhancement dengue hemorrhagic fever model. PLoS Med 2009; 6:e1000171.
6. Libraty DH, Endy TP, Houng HH et al. Differing influences of viral burden and immune activation on disease severity in secondary dengue 3 virus infections. J Infect Dis 2002; 185:1213-21.
7. Chau TN, Hieu NT, Anders KL et al. Dengue virus infections and maternal antibody decay in a prospective birth cohort study of Vietnamese infants. J Infect Dis 2009; 200:1893-900.
8. + T cell responses in relation to commencement of capillary leakage in children with dengue. J Immunol 2010; 184:7281-7.
9. Khor CC, Chau TN, Pang J et al. Genome-wide association study identifies susceptibility loci for dengue shock syndrome at MICB and PLCE1. Nat Genet 2011; 43:1139-41.
10. Midgley CM, Bajwa-Joseph M, Vasanawathana S et al. An in-depth analysis of original antigenic sin in dengue virus infection. J Virol 2010; 85:410-21.
11. Shultz LD, Ishikawa F, Greiner DL. Humanized mice in translational biomedical research. Nat Rev 2007; 7:118-30.
12. Murphy BR, Whitehead SS. Immune response to dengue virus and prospects for a vaccine. Annu Rev Immunol 2011; 29:587-619.
13. Bente DA, Melkus MW, Garcia JV, Rico-Hesse R. Dengue fever in humanized NOD/SCID mice. J Virol 2005; 79:13797-9.
14. Jaiswal S, Pearson T, Friberg H, Shultz LD, Greiner DL, Rothman AL, Mathew A. Dengue virus infection and virus-specific HLA-A2 restricted immune responses in humanized NOD-scid IL2rγnull mice. PLoS One 2009; 4:e7251.
15. -/- (RAG-hu) mice. Virology 2007; 369:143-52.
16. Mota J, Rico-Hesse R. Humanized mice show clinical signs of dengue fever according to infecting virus genotype. J Virol 2009; 83:8638-45.
17. Melkus MW, Estes JD, Padgett-Thomas A et al. Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat Med 2006; 12:1316-22.
18. Brainard DM, Seung E, Frahm N et al. Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT mice. J Virol 2009; 83:7305-21.
19. Denton PW, Olesen R, Choudhary SK et al. Generation of HIV latency in humanized BLT mice. J Virol 2012; 86:630-4.
20. Wege AK, Melkus MW, Denton PW, Estes JD, Garcia JV. Functional and phenotypic characterization of the humanized BLT mouse model. Curr Top Microbiol Immunol 2008; 324:149-65.
21. Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam AV. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol 1992; 30:545-51.
22. + T cells display quantitative and qualitative differences in their response to variant epitopes of heterologous viral serotypes. J Immunol 2006; 176:2817-24.
23. Mathew A, Rothman AL. Understanding the contribution of cellular immunity to dengue disease pathogenesis. Immunol Rev 2008; 225:300-13.
24. Brehm MA, Cuthbert A, Yang C et al. Parameters for establishing humanized mouse models to study human immunity: analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2rγ(null) mutation. Clinical Immunol 2010; 135:84-98.
25. Brehm MA, Shultz LD, Greiner DL. Humanized mouse models to study human diseases. Curr Opin Endocrinol Diabetes Obes 2010; 17:120-5.
26. Watanabe Y, Takahashi T, Okajima A et al. The analysis of the functions of human B and T cells in humanized NOD/shi-scid/γc(null) (NOG) mice (hu-HSC NOG mice). Int Immunol 2009; 21:843-58.
27. Becker PD, Legrand N, van Geelen CM et al. Generation of human antigen-specific monoclonal IgM antibodies using vaccinated "human immune system" mice. PLoS One 2010; 5:e13137.
28. Yajima M, Imadome K, Nakagawa A et al. A new humanized mouse model of Epstein-Barr virus infection that reproduces persistent infection, lymphoproliferative disorder, and cell-mediated and humoral immune responses. J Infect Dis 2008; 198:673-82.
29. Duangchinda T, Dejnirattisai W, Vasanawathana S, Limpitikul W, Tangthawornchaikul N, Malasit P, Mongkolsapaya J, Screaton G. Immunodominant T-cell responses to dengue virus NS3 are associated with DHF. Proc Nat Acad Sci USA 2010; 107:16922-7.
30. Mathew A, Kurane I, Green S et al. Predominance of HLA-restricted cytotoxic T-lymphocyte responses to serotype-cross-reactive epitopes on nonstructural proteins following natural secondary dengue virus infection. J Virol 1998; 72:3999-4004.
31. + cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a. J Clin Invest 1996; 98:1684-94.
32. Schmidt MR, Appel MC, Giassi LJ, Greiner DL, Shultz LD, Woodland RT. Human BLyS facilitates engraftment of human PBL derived B cells in immunodeficient mice. PLoS One 2008; 3:e3192.
33. Traggiai E, Becker S, Subbarao K et al. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat Med 2004; 10:871-5.
34. -/- mice. Proc Nat Acad Sci USA 2006; 103:15951-6.
35. Traggiai E, Chicha L, Mazzucchelli L, Bronz L, Piffaretti JC, Lanzavecchia A, Manz MG. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 2004; 304:104-7.
36. Ishikawa F, Yasukawa M, Lyons B et al. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ-chain(null) mice. Blood 2005; 106:1565-73.
37. + B cells. Immunology 2011; 134:419-33.